How big is the sentinel node biopsy market?

The global sentinel node biopsy market size was estimated at USD 717.83 million in 2023 and is expected to reach USD 755.9 million in 2024.

What is the sentinel node biopsy market growth?

The global sentinel node biopsy market is expected to grow at a compound annual growth rate of 7.0% from 2024 to 2030 to reach USD 1.1 billion by 2030.

Which segment accounted for the largest sentinel node biopsy market share?

The breast cancer segment held the largest revenue share of 61.51% in the market in 2023 due to the increasing prevalence of breast cancer worldwide.

Who are the key players in the sentinel node biopsy market?

Some key market players operating in the global sentinel node biopsy market include Hologic, Inc., Devicor Medical Products, Inc., KUBTEC, SurgicEye GmbH, Varay Laborix, LabLogic Systems Ltd (Care Wise), Gamma Medical Technology, and Stryker.

What are the factors driving the sentinel node biopsy market?

The growth of the sentinel node biopsy market can be attributed to the technological advancements in instruments used for sentinel node biopsy and the rising prevalence of cancer.